Patent Application for Dichrostachys glomerata to Reduce Anxiety and Stress

The USPTO has published a new patent application (US20260083796A1) detailing methods and compositions using Dichrostachys glomerata to reduce anxiety, stress, and food cravings, while improving mood and overall health in mammals. The application was filed on September 26, 2024, by inventor Shil Kothari.

Patent Application for Dichrostachys glomerata Health Benefits

The USPTO has published a patent application (US20260083794A1) detailing methods and compositions using Dichrostachys glomerata for various health benefits, including reducing anxiety and improving mood. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.

Patent Application: Dichrostachys glomerata for Anxiety and Stress Reduction

The USPTO has published a patent application (US20260083793A1) detailing methods and compositions using Dichrostachys glomerata to reduce anxiety, stress, and food cravings, while improving mood and energy. The application was filed on September 25, 2024, by inventor Shil Kothari.

Patent Application for Dichrostachys glomerata to Reduce Anxiety and Cravings

The USPTO has published a new patent application (US20260083792A1) for methods and compositions using Dichrostachys glomerata to reduce anxiety, stress, food cravings, and improve mood and overall health. The application was filed on September 25, 2024, by inventor Shil Kothari.

Patent Application: Dichrostachys glomerata Health Benefits

The USPTO has published a patent application (US20260083791A1) detailing methods and compositions using Dichrostachys glomerata for various health benefits, including reducing anxiety, food cravings, and stress, and improving mood and energy. The application was filed on September 25, 2024, by inventor Shil Kothari.

Formulation for Hair Growth

The USPTO has published a new patent application, US20260083789A1, for a formulation designed to stimulate hair growth and improve hair quality. The formulation primarily utilizes a nitrate-enriched extract of Amaranth, along with other plant-based ingredients. The application details the method of preparation and its potential use in enhancing hair growth rate, count, and density.

Antiviral Fungal Extracts Prevent Coronavirus Infections

The USPTO has published a patent application (US20260083788A1) detailing antiviral fungal extracts that may prevent coronavirus infections by interfering with the Spike protein. The application, filed by Mycotech Pharma AS, describes compositions derived from Agaricus blazei, Grifola frondosa, and Hericium erinaceus.

GABA-producing bacteria for improving health patent application

The USPTO has published a new patent application (US20260083786A1) detailing a composition comprising Lactobacillus brevis (NCIMB 41903) for use in regulating or treating metabolic diseases. The application was filed on September 17, 2025, by inventors Paul Ross and Catherine Stanton.

Patent Application: Bifidobacterium longum for Infant Infection Prevention

The USPTO has published a patent application (US20260083785A1) detailing the use of Bifidobacterium longum transitional microorganisms to prevent or reduce the risk of infection in infants and young children. The application was filed on September 27, 2023.

FDA Decision on Tradipitant New Drug Application Refusal

The Food and Drug Administration (FDA) has issued a final decision regarding the new drug application for Tradipitant. The agency has decided to refuse to approve the application, based on a proposal to do so. The specific details of the decision are confidential business information, but a redacted version is available.